35

DAFTAR PUSTAKA

Kasper, D.,L., Fauci, A.,S., Hauser, S.,L., Longo, D.,L., Jameson, J.,L., Loscalzo, J.
2015. Harrison's Principles of Internal Medicine 19th ed. New york: McGraw-
Hill.
Kementerian Kesehatan RI. 2015. Pusat Data dan Informasi Kementerian Kesehatan
RI. Situasi dan Analisis HIV AIDS: 1-8
Atfeld M., Bunders M., J. 2016. Impact of maternal HIV-1 infection on the feto-
maternal crosstalk and consequences for pregnancy outcome and infant health.
Semin Immunopathol: 1-12.
Department of HIV/AIDS, Department of Reproductive Health and Research. 2004.
Antiretroviral Drugs For Treating Pregnant Women and Preventing HIV
Infection in Infants. Dalam: Guidelines on Care, Treatment and Support for
Women Living With HIV/AIDS and Their Children in Resource-Constrained
Settings. Geneva: WHO: 1-41.
Toha Muhaimin dan Besral. 2011. Prevalensi HIV Pada Ibu Hamil di Delapan Ibu Kota
Provinsi di Indonesia Tahun 2003-2010. Makara Kesehatan, 15(2): 93-100.
French R., Peter B., dkk. 1998. The effect of pregnancy on survival in women infected
with HI\ a systematic review of the literature and meta-analysis. British Journal
of Obstetrics and Gynaecology, 105: 827-835.
Cunningham F., G., Leveno K., J., Bloom S., L., Spong C., Y., Dashe J.,S, Hoffman
B.,L., dkk. 2014. Williams's Obstetrics 24th ed. New York: McGraw-Hill,
1276-1282.
Hladik F., Sakchalathorn P., Ballweber L., Lentz G., Fialkow M., Eschenbach D., dkk.
2007. Initial events in establishing vaginal entry and infection by human
immunodeficiency virus type-1. Immunity, 26: 257–270.
Hackemann M., Grubb C., Hill K.,R. 1968. The ultrastructure of normal squamous
epithelium of the human cervix uteri. J Ultrastruct Res, 22: 443–457.
 36

Zaitseva M., Blauvelt A., Lee S., Lapham C.,K., Klaus-Kovtun V., Mostowski H., dkk.
1997. Expression and function of CCR5 and CXCR4 on human Langerhans
cells and macrophages: implications for HIV primary infection. Nat Med,
1369–1375.
Weissman D., Rubbert A., Combadiere C., Murphy P.,M., Fauci A.,S. 1997. Dendritic
cells express and use multiple HIV coreceptors. Adv Exp Med Biol, 417: 401–
406.
Miller C.,J., McChesney M., Moore P.,F. 1992. Langerhans cells, macrophages and
lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab Invest,
67: 628–634.
Miller C.,J., McGhee J.,R., Gardner M.,B. 1992. Mucosal Immunity, HIV transmission
and AIDS. Lab Invest, 68: 129–145.
Pangkawira E., Kiki M.,K., Samsi. 2009. Vaksin HIV: Harapan atau Khayalan? CDK
170, 36:(4) p251 – 255.
Taylor Barbara S., Magdalena E., Sobieszyk, dkk. 2008. The Challenge of HIV-1
Subtype Diversity. N.Engl.J.Med., 358:15.
Yoveline A., Wahyuningsih R., Kumalawati Y., dkk. 2008. Peran Rapid Oral HIV Test
dalam Diagnosis Infeksi HIV. Maj Kedokt Indon., 58(12): 525-531.
Direktorat Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan.
2003. Pedoman nasional perawatan, dukungan, dan pengobatan bagi ODHA.
Jakarta: Departemen Kesehatan RI.
Kudesia G., Wreghitt T. 2009. Clinical and Diagnostic Virology. Cambridge:
Cambridge University Press.
Conway S., Bartlett J.,G. 2003. Graph found in PowerPoint presentation titled
“Window Period: Untreated Clinical Course.” 40.
Dutta D. 2013. DC Dutta's Textbook of Obstetrics. 7th ed. New Delhi: Jaypee Brothers
Medical Publishers.
 37

Vermaak A., Theron G.,B., Schubert P.,T., Kidd M., Rabie U., Adjiba B.,M., dkk.
2012. Morphologic changes in the placentas of HIV-positive women and their
association with degree of immune suppression. International Journal of
Gynecology and Obstetrics, 119: 239-243.
Munoz C.,E., Romero F.,L., Chavez J.,Z., dkk. 2012. Effects of progesterone on the
content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and
exposed but uninfected Mexican women to HIV-1. Journal of Steroid
Biochemistry & Molecular Biology, 132: 66– 72.
Prawirohardjo, S. 2009. Ilmu Kebidanan. Jakarta, PT Bina Pustaka.
Moodley J. 2013. Impact of HIV on the incidence of pre-eclampsia. Cardiovascular
Journal Of Africa, 24(2): 5.
European Collaborative Study. 2003. Pregnancy-related changes in the longer-term
management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod
Biol, 111: 3–8.
Suy Anna dkk. 2006. Increased risk of pre-eclampsia and fetal death in HIV-infected
pregnant women receiving highly active antiretroviral therapy. AIDS, 20(1): 59-
66.
Hoffman Madelein. 2015. E-Selectin, and markers of HIV disease severity,
inflammation and coagulation in treatment- naïve individuals living with HIV.
Stellenbosch University. Http://scholar.sun.ac.za. Diakses tanggal 5 Januari
2018.
Calza L., Pocacetra D., Colangeli V., dkk. 2009. Plasma Levels of VCAM-1, ICAM-
1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-
Negative Healthy Controls. J Acquir Immune Defic Syndr, 50(4): 430- 435.
Wimalasundera RC dkk. 2002. Pre-eclampsia, antiretroviral therapy, and immune
reconstitution. Lancet, 360: 1152–54.
 38

Adams J.,W., dkk. 2015. A systematic review of the effect of HIV infection and
antiretroviral therapy on the risk of pre-eclampsia. Int J Gynecol Obstet,
Http://dx.doi.org/10.1016/j.ijgo.2015.08.007. Diakses 5 November 2017.
Landi, B., dkk. 2014. HIV Infection in Pregnancy and the Risk of Gestational
Hypertension and Preeclampsia. World Journal of Cardiovascular Diseases, 4:
257-267.
Kakkar F dkk. 2014. Impact of maternal HIV-1 viremia on lymphocyte subsets among
HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
BMC Infect Dis, 14:236.
Aagaard K dkk. 2014. The placenta harbors a unique microbiome. Sci Transl Med,
6(237): 237-65.
Marinda E., dkk. 2007. Child mortality according to maternal and infant HIV status in
Zimbabwe. Pediatr Infect Dis J, 26(6): 519–526.
Newell M.,L., Bunders M.,J. 2013. Safety of antiretroviral drugs in pregnancy and
breastfeeding for mother and child. Curr Opin HIV AIDS, 8(5): 504–510.
Johnstone F., D. 1992. The effect of HIV infection on pregnancy outcome. Bailli~re's
Clinical Obstetrics and Gynecology, 6(2): 69-84.
Dadhwal dkk. 2017. Pregnancy Outcomes in HIV-Infected Women: Experience from
a Tertiary Care Center in India. International Journal of MCH and AIDS, 6(1):
75-81.
Olagbuji B.,N., Ezeanochie M.,C., Ande A.,B., Oboro V.,O. 2010. Obstetric and
perinatal outcome in HIV positive women receiving HAART in urban Nigeria.
Archives of Gynecology and Obstetrics, 281(6): 991-94.
Ekouevi D.,K., Coffie P.,A., Becquet R., Tonwe Gold B., dkk. 2008. Antiretroviral
therapy in pregnant women with advanced HIV disease and pregnancy
outcomes in Abidjan, Côte d’Ivoire. AIDS, 22(14): 1815-20.
KEMENKES RI. 2011. Buku Pedoman Nasional Terapi Antiretroviral tahun 2011
Jakarta: Kemenkes RI.
 39

Berghella V. 2017. Maternal-Fetal Evidence Based Guidelines. Massachutes: Taylor

& Francis.
Townsend C., dkk. 2010. Antiretroviral therapy and preterm delivery-a pooled analysis
of data from the United States and Europe. BJOG, 117(11): 1399–1410.
Chen J.,Y., dkk. 2012. Highly active antiretroviral therapy and adverse birth outcomes
among HIV-infected women in Botswana. J Infect Dis, 206(11): 1695–705